See also this year's filing and all EDGAR filings for this company.
PDF Report 0001649904_2023_RHYTHM_PHARMACEUTICALS_INC.pdf
Logs
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 10, '00205 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (calc 2)': 2}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001649904, RHYTHM PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 354,236,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 7,883,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,197,000 |
| 3 | remainder_Assets | 18,165,000 |
| 4 | LiabilitiesCurrent | 39,809,000 |
| 5 | LiabilitiesNoncurrent | 1,260,000 |
| 6 | remainder_Liabilities | 77,150,000 |
| 7 | CostOfGoodsAndServicesSold | 2,133,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 92,032,000 |
| 9 | ResearchAndDevelopmentExpense | 108,630,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 23,638,000 |
| 12 | remainder_NetIncome | -1,962,000 |
| 13 | remainder_ComprehensiveNetIncome | -91,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 382,481,000 |
| 1 | Liabilities | 118,219,000 |
| 2 | Expenses | 202,795,000 |
| 3 | Revenues | 23,638,000 |
| 4 | StockholdersEquity | 264,262,000 |
| 5 | NetIncome | -181,119,000 |
| 6 | ComprehensiveNetIncome | -181,164,500 |
| 7 | BaseVar | 364,593,000 |
| 8 | EconomicCapitalRatio | 1.09 |
Edgar->Model Mapping
Feature Distribution
Change over Time
